Cart
sales@molnova.com
WAY-270360
CAS No. 476633-98-4
WAY-270360( N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide )
Catalog No. M28522 CAS No. 476633-98-4
WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 135 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 332 | In Stock |
|
| 50MG | 456 | In Stock |
|
| 100MG | 642 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1274 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-270360
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
-
DescriptionWAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsN-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number476633-98-4
-
Formula Weight373.412
-
Molecular FormulaC22H19N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(C(=O)Nc2ccc(cc2)-c2nc3ccccc3[nH]2)c(OC)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Almonertinib mesylat...
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
-
Daphnetin
Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.
-
Lapatinib ditosylate...
Lapatinib ditosylate is an anti-Y drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung Y.
